The US Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries. The approval was announced by Dr. Reddy’s Laboratories, the Indian maker of the generic version of lenacapavir, and by Unitaid, a global health initiative.
The post US approves cheap version of breakthrough HIV prevention shot: manufacturer appeared first on Insider Paper.
